Molina J-M, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD Noninferiority trial. AIDS 2018.
Niet-invasieve screening op maagkanker: S. anginosus en S. constellatus
sep 2022 | Maag-darm-leveroncologie